Roche Smart-Bomb Cancer Drug Delays Breast Tumor Growth

An experimental breast cancer drug from Roche Holding AG that carries chemotherapy directly into malignant cells while bypassing healthy ones delayed tumors longer and with fewer side effects than an established therapy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.